anti-PAT mAb1 antibody product blog
Tags: Antibody; Monoclonal Antibody; PAT mAb1; anti-PAT mAb1 antibody;
The PAT mAb1 n/a (Catalog #MBS478115) is an Antibody produced from Mouse ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s PAT mAb1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Lateral Flow Immunoassay.ELISA, Lateral Flow Immunoassay(double antibody test for PAT detection) as well as in Western blot.
Other applications have not been tested but use in such assays should not be excluded.
Performance Review:
- Great activity for PAT in GMO plant and recombinant PAT
- Capable of creating test with sensitivity of 5 ng/ml PAT.
-Recommended pair for double antibody immunoassay:
Capture: MBS478058; Detection: MBS478115. Researchers should empirically determine the suitability of the PAT mAb1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Monoclonal antibody to phosphinothricin-N-acetyltransferase (PAT) encoded by Bialaphos resistance (bar) gene.
Immunogen: Recombinant phosphinothricin-N-acetyltransferase from Escherichia coli BL21(DE3). Note: Centrifuge before opening to ensure complete recovery of vial contents. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing PAT mAb1 are readily searchable from our website. Different antibodies against the same target such as PAT mAb1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.